Foca Project covers a highly prospective land package in an under explored mineral belt between the Rupice Mine (Adriatic ...

TORONTO, ON / ACCESSWIRE / November 25, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") announces that the Board of Directors has revised the vesting schedule of the R ...

TUCSON, AZ / ACCESSWIRE / November 25, 2024 / Applied Energetics, Inc. (OTCQB:AERG), a leader in the field of advanced optical technologies and ultrashort pulse laser (USPL) technologies, today ...

JERICHO, NY / ACCESSWIRE / November 25, 2024 / "For many years BNK has provided well-received financial research websites to the public, each of which brings specific utility to stock market ...

Founder Group Limited (NASDAQ: FGL) ("Founder Group" or the "Company"), a leading engineering, procurement, construction, and commissioning ...

SCOTTSDALE, Ariz., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH, "Meritage" or the "Company"), the fifth-largest homebuilder in the U.S., today announced that its Board of ...

WASHINGTON (dpa-AFX) - Stocks have moved mostly higher during trading on Monday, adding to the strong gains posted last week. With the upward move, the Dow and the S&P 500 have reached new record ...

MEMPHIS, TN / ACCESSWIRE / November 25, 2024 / FedEx has been named a 2024 "Top Company for Women to Work in Transportation" by Redefining the Road, the official magazine of Women In Trucking Associat ...

STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced ...

California Resources Corporation (NYSE: CRC), an independent energy and carbon management company committed to energy transition, today announced ...

SAN RAFAEL, Calif., Nov. 25, 2024 /PRNewswire/ - Damon Inc. (Nasdaq: DMN) ("Damon" or the "Company"), maker of advanced electric motorcycles, today announced the ...

Simufilam did not show a significant reduction in cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer's disease in the ReThink-ALZ Phase 3 study Simufilam contin ...